prikaz prve stranice dokumenta Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023
  Preuzmi
PDF 1.12 MB
Znanstveni rad - Izvorni znanstveni rad
Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023
JAMA Network Open, 7 (2024), 9; e2434077. https://doi.org/10.1001/jamanetworkopen.2024.34077
(International Neonatal Transfusion Point Prevalence Study Group) Houben, Nina A. M.; Fustolo-Gunnink, Suzanne; Fijnvandraat, Karin; Caram-Deelder, Camila; Carrascosa, Marta Aguar; Beuchée, Alain; Brække, Kristin; Cardona, Francesco; Debeer, Anne; Domingues, Sara; Ghirardello, Stefano; Grizelj, Ruza; Hadžimuratović, Emina; Heiring, Christian; Krivec, Jana Lozar; Malý, Jan; Matasova, Katarina; Moore, Carmel Maria; Muehlbacher, Tobias; Szabó, Miklos; Szczapa, Tomasz; Zaharie, Gabriela; de Jager, Justine; Reibel-Georgi, Nora Johanna; New, Helen V.; Stanworth, Simon J.; Deschmann, Emöke; Roehr, Charles C.; Dame, Christof; le Cessie, Saskia; van der Bom, Johanna; Lopriore, Enrico Više autora...

Citirajte ovaj rad

Houben, N. A. M., Fustolo Gunnink, S., Fijnvandraat, K., Caram Deelder, C., Carrascosa, M. A., Beuchée, A. ... Lopriore, E. (2024). Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023. JAMA Network Open, 7. (9). doi: 10.1001/jamanetworkopen.2024.34077

Houben, Nina A. M., et al. "Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023." JAMA Network Open, vol. 7, br. 9, 2024. https://doi.org/10.1001/jamanetworkopen.2024.34077

Houben, Nina A. M., Suzanne Fustolo Gunnink, Karin Fijnvandraat, Camila Caram Deelder, Marta Aguar Carrascosa, Alain Beuchée, Kristin Brække, et al. "Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023." JAMA Network Open 7, br. 9 (2024). https://doi.org/10.1001/jamanetworkopen.2024.34077

Houben, N. A. M., et al. (2024) 'Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023', JAMA Network Open, 7(9). doi: 10.1001/jamanetworkopen.2024.34077

Houben NAM, Fustolo Gunnink S, Fijnvandraat K, Caram Deelder C, Carrascosa MA, Beuchée A, i sur.. Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023. JAMA Network Open [Internet]. 19.09.2024. [pristupljeno 03.04.2025.];7(9). doi: 10.1001/jamanetworkopen.2024.34077

N. A. M. Houben, et al., "Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023", JAMA Network Open, vol. 7, br. 9, Rujan 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:553138. [Citirano: 03.04.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:553138
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023
AutorNina A. M. Houben
AutorSuzanne Fustolo-Gunnink
AutorKarin Fijnvandraat
AutorCamila Caram-Deelder
AutorMarta Aguar Carrascosa
AutorAlain Beuchée
AutorKristin Brække
AutorFrancesco Cardona
AutorAnne Debeer
AutorSara Domingues
AutorStefano Ghirardello
AutorRuza Grizelj
AutorEmina Hadžimuratović
AutorChristian Heiring
AutorJana Lozar Krivec
AutorJan Malý
AutorKatarina Matasova
AutorCarmel Maria Moore
AutorTobias Muehlbacher
AutorMiklos Szabó
AutorTomasz Szczapa
AutorGabriela Zaharie
AutorJustine de Jager
AutorNora Johanna Reibel-Georgi
AutorHelen V. New
AutorSimon J. Stanworth
AutorEmöke Deschmann
AutorCharles C. Roehr
AutorChristof Dame
AutorSaskia le Cessie
AutorJohanna van der Bom
AutorEnrico Lopriore
KolaboracijaInternational Neonatal Transfusion Point Prevalence Study Group
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA PEDIJATRIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Pedijatrija
Sažetak (engleski)
Importance: Red blood cell (RBC) transfusions are frequently administered to preterm infants born before 32 weeks of gestation in the neonatal intensive care unit (NICU). Two randomized clinical trials (Effects of Transfusion Thresholds on Neurocognitive Outcomes of Extremely Low-Birth-Weight Infants [ETTNO] and Transfusion of Prematures [TOP]) found that liberal RBC transfusion thresholds are nonsuperior to restrictive thresholds, but the extent to which these results have been integrated into clinical practice since publication in 2020 is unknown. Objective: To describe neonatal RBC transfusion practice in Europe. Design, setting, and participants: This international prospective observational cohort study collected data between September 1, 2022, and August 31, 2023, with a 6-week observation period per center, from 64 NICUs in 22 European countries. Participants included 1143 preterm infants born before 32 weeks of gestation. Exposure: Admission to the NICU. Main outcomes and measures: Study outcome measures included RBC transfusion prevalence rates, cumulative incidence, indications, pretransfusion hemoglobin (Hb) levels, volumes, and transfusion rates, Hb increment, and adverse effects of RBC transfusion. Results: A total of 1143 preterm infants were included (641 male [56.1%]; median gestational age at birth, 28 weeks plus 2 days [IQR, 26 weeks plus 2 days to 30 weeks plus 2 days]; median birth weight, 1030 [IQR, 780-1350] g), of whom 396 received 1 or more RBC transfusions, totaling 903 transfusions. Overall RBC transfusion prevalence rate during postnatal days 1 to 28 was 3.4 transfusion days per 100 admission days, with considerable variation across countries, only partly explained by patient mix. By day 28, 36.5% (95% CI, 31.6%-41.5%) of infants had received at least 1 transfusion. Most transfusions were given based on a defined Hb threshold (748 [82.8%]). Hemoglobin levels before transfusions indicated for threshold were below the restrictive thresholds set by ETTNO in 324 of 729 transfusions (44.4%) and TOP in 265 of 729 (36.4%). Conversely, they were between restrictive and liberal thresholds in 352 (48.3%) and 409 (56.1%) transfusions, respectively, and above liberal thresholds in 53 (7.3%) and 55 (7.5%) transfusions, respectively. Most transfusions given based on threshold had volumes of 15 mL/kg (470 of 738 [63.7%]) and were administered over 3 hours (400 of 738 [54.2%]), but there was substantial variation in dose and duration. Conclusions and relevance: In this cohort study of very preterm infants, most transfusions indicated for threshold were given for pretransfusion Hb levels above restrictive transfusion thresholds evaluated in recent trials. These results underline the need to optimize practices and for implementation research to support uptake of evidence.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaJAMA Network Open
Brojčani podacivol. 7, br. 9, e2434077
e-ISSN2574-3805
DOIhttps://doi.org/10.1001/jamanetworkopen.2024.34077
URN:NBNurn:nbn:hr:105:553138
Datum objave publikacije2024-09-19
URL dokumentahttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823754
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2025-03-20 08:44:37